Location:
Ghent University Hospital,Belgium Remifentanil, an ultra-short acting synthetic opioid, is an important intraoperative analgesic agent. Being able to reliably detect its physiological effect is an important step towards monitoring the analgesic state of a patient. This study involved the reanalysis of electroencephalographic (EEG) data recorded during propofol-remifentanil anaesthesia and showed that the BAR methodology, unlike existing EEG monitoring approaches, was capable of differentiating the effects of the anaesthetic agent propofol from the analgesic agent remifentanil.
Anesthesiology - Editorial : Disentangling Hypnos from His Poppies
| Attachment | Size |
|---|---|
| Remifentanil Poster FINAL.pdf | 169.78 KB |
